Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 (mirogabalin) in painful diabetic peripheral neuropathy
jRCT2080221671Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of mirogabalin in diabetic polyneuropathy (DPN) (5 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Average Daily Pain Score (ADPS) change from baseline. Started Dec 2011; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on jRCT2080221671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221671.